Sesame Care vs Ro.co: Clinician Choice or Wegovy Pill?
Quick answer: Sesame Care vs Ro.co — which fits you?
Sesame Care is a telehealth marketplace that emphasizes clinician choice and starts subscriptions at $59/mo* with cash-pay GLP-1 meds as low as $149/mo; Ro.co starts at $39 and is the only mainstream platform here offering the FDA-approved Wegovy pill. Early verdict: choose Sesame Care if you want to browse and select from a large clinician network; choose Ro.co if access to the branded oral Wegovy pill or an injection-free FDA-approved option is your priority.
Explore Sesame Care clinician options
How they differ at a glance
Comparing Sesame Care vs Ro.co centers on four clear differences supported by the sources: clinician selection model, oral versus injectable medication access, pricing entry points and medication costs, and regulatory status of offered products. The table below summarizes those differences.
| Criteria | Sesame Care | Ro.co |
|---|---|---|
| Business model | Telehealth marketplace; browse and choose clinicians | Full-service telehealth platform prescribing branded meds |
| Starting price | Subscriptions from $59/mo* | Get started online for just $39 |
| Medication types | Cash-pay GLP-1 meds as low as $149/mo; semaglutide and tirzepatide options listed | Offers Wegovy pill, FDA-approved oral GLP-1; branded finished products |
| Insurance | Insurance accepted for weight loss medications; medication cost varies by insurance and pharmacy | Ongoing branded medication pricing varies; insurance coverage inconsistent and often paid out of pocket |
| Regulatory note | Medication-specific approval status must be confirmed | Wegovy pill is FDA-approved; compounded meds are not FDA-approved |
Clinician choice and care model
Sesame Care positions itself as a marketplace where patients can browse and select providers based on specialty, availability, and pricing. The source describes a “large clinician network” and emphasizes flexible scheduling and nationwide access in many states. That model means experience may vary by clinician because patients choose individual clinicians rather than being assigned by an algorithmic queue.
Ro.co is described as an established, full-service telehealth platform with brand trust. The source does not describe a marketplace-style clinician selection process; instead Ro focuses on delivering FDA-approved branded medications like the Wegovy pill through a licensed clinician review when medically appropriate.
Medication access: oral Wegovy pill versus marketplace medication options
One of the most distinctive differences in Sesame Care vs Ro.co is medication form. Ro.co is the only mainstream platform in the captured sources that offers access to the Wegovy pill, the first FDA-approved oral GLP-1 weight loss medication. That gives Ro.co a clear edge for patients who prefer an FDA-evaluated oral route instead of injections or compounded products.
Sesame Care lists access to semaglutide and tirzepatide options and notes cash-pay GLP-1 medications as low as $149/mo, with specific pricing tiers and strengths provided for different branded injectables. The source also flags that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable.
Pricing structure and insurance notes
Both providers disclose different entry prices and approaches to medication cost. Sesame Care advertises ongoing video visits, dedicated provider care, labs, and messaging for as low as $59/mo* based on a 12-month Success by Sesame commitment. Cash-pay GLP-1 medications are described as low as $149/mo for semaglutide with price-with-insurance examples as low as $25 for some strengths; tirzepatide cash-pay examples are listed at $299 and up with insurance prices noted as low as $25.
Ro.co highlights a $39 get-started price and emphasizes that the Wegovy pill and other branded medications carry higher costs than compounded alternatives. The source states Ro does not charge hidden fees and that ongoing branded medication pricing depends on the treatment plan and medication prescribed. Insurance coverage for GLP-1 weight loss medication is noted as inconsistent and often paid out of pocket.
Regulatory clarity and compounded medications
Ro.co emphasizes that the Wegovy pill is an FDA-approved finished medication and notes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. Sesame Care’s materials include a regulatory note saying medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable. Both sources therefore highlight different trade-offs: Ro.co highlights regulatory clarity for branded oral products, while Sesame Care offers broader marketplace options that may include varied medication types and clinician approaches.
How to decide: Choose based on these differences
Choose Sesame Care if you want the ability to browse and select from a large clinician network, value flexible scheduling, and prefer a marketplace model with subscriptions starting from $59/mo* and cash-pay GLP-1 options from $149/mo. Choose Ro.co if access to the FDA-approved Wegovy pill and an injection-free, regulator-evaluated oral GLP-1 route is your priority and you value a clear branded medication path starting with a $39 get-started price.
Browse Sesame Care clinicians and pricing
Start with Sesame Care subscriptions
Final takeaway: Sesame Care vs Ro.co
Sesame Care vs Ro.co comes down to clinician choice and marketplace flexibility versus exclusive access to an FDA-approved oral option. The primary keyword Sesame Care vs Ro.co summarizes the trade-off: pick Sesame Care for broad clinician choice and flexible subscription options, pick Ro.co if the Wegovy pill and FDA-approved oral GLP-1 medication are decisive for you. Medication costs, insurance acceptance, and medication-specific approval status vary and should be confirmed with each provider and your clinician.